ArticleJournal of Cancer2025

Single-fraction high-dose-rate brachytherapy as monotherapy for localized prostate cancer: long-term follow-up study based on meta-analysis.

Li Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.